Trabectedin--a targeted chemotherapy?
von Mehren
Margaret
M
D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D004149:Dioxoles / Q000627:therapeutic use*; D018572:Disease-Free Survival; D006801:Humans; D018208:Liposarcoma, Myxoid / Q000188:drug therapy* / Q000473:pathology; D015514:Oncogene Proteins, Fusion / Q000235:genetics / Q000378:metabolism; D044005:Tetrahydroisoquinolines / Q000627:therapeutic use*; D000077606:Trabectedin
D018906:Antineoplastic Agents, Alkylating; D004149:Dioxoles; D015514:Oncogene Proteins, Fusion; D044005:Tetrahydroisoquinolines; D000077606:Trabectedin